Application of immunotherapy in advanced non-small cell lung cancer with hypertension: a multicenter retrospective analysis

ImportanceImmune checkpoint inhibitors (ICIs) have become the standard treatment for advanced non-small cell lung cancer (NSCLC). However, their prognostic role in NSCLC patients remains controversial. Hypertension (HTN) is an important risk factor for many cancers, but the pathogenesis underlying H...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jingyi Yuan, Kaixin Lei, Quanling Kong, Tao Chang, Xinhang Gu, Juan Wang, Li-na He, Jiadi Gan, Bojiang Chen
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-09-01
Serija:	Frontiers in Oncology
Teme:	immune checkpoint inhibitor hypertension non-small cell lung cancer PD-1/PD-L1 inhibitors prognosis
Online dostop:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1621363/full
Oznake:	Označite Brez oznak, prvi označite!